Deep Learning for the Accurate Prediction of Triggered Drug Delivery.

Area of Science:

• Nanotechnology and Materials Science
• Biomedical Engineering
• Computational Chemistry

Background:

• Chemotherapy's adverse effects necessitate advanced drug delivery systems.
• Nanoparticles offer precise delivery of chemotherapeutic agents.
• Targeted and triggered release mechanisms are crucial for enhanced efficacy.

Purpose of the Study:

• To investigate the drug delivery capabilities of liposomes and metal-organic frameworks (MOFs) using passive, active, and triggered targeting.
• To develop a predictive model for drug release from nanocarriers using deep learning and experimental data.
• To evaluate the efficacy of various triggering techniques (ultrasound, microwave, UV, pH) on drug release.

Main Methods:

• Utilized liposomes and MOFs as nanocarriers for chemotherapeutic agents.
• Employed passive, active (ligand-based), and triggered targeting strategies.
• Developed a predictive model integrating experimental measurements with deep learning techniques.
• Assessed drug release under diverse conditions: low/high-frequency ultrasound, microwave, UV light, and varying pH levels.

Main Results:

• The developed deep learning model accurately predicted drug release from liposomes and MOFs.
• Deep learning predictions significantly outperformed traditional linear predictions.
• Demonstrated the effectiveness of various intrinsic (pH) and extrinsic (ultrasound, microwave, UV) triggers for controlled drug release.
• Confirmed the potential of modified liposomes and MOFs for targeted cancer therapy.

Conclusions:

• Nanocarriers like liposomes and MOFs show significant promise for targeted chemotherapy.
• Deep learning models are highly effective in predicting nanocarrier drug release behavior.
• This approach paves the way for optimized and enhanced cancer treatment strategies through precise drug delivery.